Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q02153
UPID:
GCYB1_HUMAN
Alternative names:
Guanylate cyclase soluble subunit beta-3; Soluble guanylate cyclase small subunit
Alternative UPACC:
Q02153; B7Z426; Q86WY5
Background:
The Guanylate cyclase soluble subunit beta-1, also known as Guanylate cyclase soluble subunit beta-3 and Soluble guanylate cyclase small subunit, plays a pivotal role in cellular signaling. It mediates responses to nitric oxide (NO) by catalyzing the biosynthesis of the signaling molecule cGMP, a critical process in various physiological pathways.
Therapeutic significance:
Understanding the role of Guanylate cyclase soluble subunit beta-1 could open doors to potential therapeutic strategies. Its central function in NO signaling pathways suggests its involvement in critical physiological processes, making it a target of interest in drug discovery.